Search

everythinglearnresearchcommunity

for

Search:↓

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

High androgen levels often cause female hirsutism and infertility.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Hormonal factors may affect female hair loss, needing further research and treatment ideas.

Certain pesticides may delay sexual maturity in teenage boys.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

A woman had high testosterone due to an ovarian issue, which was fixed with surgery.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.